The Leloir Pathway of Galactose Metabolism – A Novel Therapeutic Target for Hepatocellular Carcinoma
Open Access
- 1 December 2016
- journal article
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 36 (12) , 6265-6272
Abstract
Hepatocellular carcinoma (HCC) is one of the most lethal types of cancer worldwide, with poor prognosis and limited treatments. In order to identify novel therapeutic targets that will lead to development of effective therapies with manageable side effects, we tested the hypothesis that knocking-down galactokinase (GALK1) or galactose-1 phosphate uridylyltransferase (GALT) gene expression would control the growth of cultured hepatoma cells. Our results showed small interfering RNA (siRNA) against GALK1 or GALT inhibited the growth of HepG2 cells in culture. Western blot analysis revealed simultaneous down-regulation of multiple players of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) growth signaling pathway, as well as heat-shock protein 90 (HSP90) and poly ADP ribose polymerase (PARP). Reverse transcription-polymerase chain reaction (RT-PCR) data, however, showed no significant mRNA reduction of the encoded genes. Our study thus not only supports GALK1 and GALT as being possible novel targets for treating HCC, but also uncovers new post-transcriptional regulatory mechanisms that link the galactose metabolic pathway to protein expression of the PI3K/AKT pathway in hepatoma.Keywords
This publication has 26 references indexed in Scilit:
- PI3K/AKT/mTOR‐dependent stabilization of oncogenic far‐upstream element binding proteins in hepatocellular carcinoma cellsHepatology, 2015
- 17-Demethoxy-reblastatin, an Hsp90 inhibitor, induces mitochondria-mediated apoptosis through downregulation of Mcl-1 in human hepatocellular carcinoma cellsJournal of Bioenergetics and Biomembranes, 2015
- Mouse Models of Liver Cancer2015
- Serum Levels of Glycoproteins are Elevated in Patients with Ovarian CancerIndian Journal of Clinical Biochemistry, 2013
- HSP90: Chaperone-me-notPathology and Oncology Research, 2013
- Transcriptome classification of HCC is related to gene alterations and to new therapeutic targetsHepatology, 2006
- Role of HSP90, CDC37, and CRM1 as modulators of P16INK4A activity in rat liver carcinogenesis and human liver cancer†Hepatology, 2005
- Targeting multiple signal transduction pathways through inhibition of Hsp90Journal of Molecular Medicine, 2004
- Overexpression of Human UDP-Glucose Pyrophosphorylase Rescues Galactose-1-Phosphate Uridyltransferase-Deficient YeastBiochemical and Biophysical Research Communications, 2000
- Long‐term prognosis in galactosaemia: Results of a survey of 350 casesJournal of Inherited Metabolic Disease, 1989